ABELSON LEUKEMIA VIRUS TRANSFORMATION
ABELSON LEUKEMIA VIRUS TRANSFORMATION
批准号:
2087231
负责人:
NAOMI ROSENBERG
金额:
$19.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-09-01 至 1996-03-31
关键词:
3T3 cells Abelson leukemia virus Retroviridae Retroviridae disease cell cycle cell differentiation cell growth regulation cell type clone cells disease /disorder model flow cytometry gel electrophoresis gene expression genetic manipulation genetic mapping hematopoietic stem cells host organism interaction immunofluorescence technique laboratory mouse laboratory rabbit leukocyte activation /transformation membrane proteins monoclonal antibody murine leukemia virus mutant nucleic acid probes oncogenic virus phase contrast microscopy protein sequence protein structure function protein tyrosine kinase transforming virus viral leukemogenesis virus cytopathogenic effect virus genetics virus protein virus replication
中文摘要
Abelson鼠白血病病毒(AbMLV)是一种快速转化的逆转录病毒
它含有癌基因v-abl。这种或其他致癌基因的表达
ABL的各种形式诱导多种类型的细胞转化并刺激
其他人的成长和分化。此外,ABL表达可以
是致命的。所有这些影响都是由单一产品介导的,该产品在
抗体-MLV的病例称为Abelson蛋白。这个分子是一个成员
非受体蛋白酪氨酸激酶家族和蛋白酪氨酸
单抗-MLV对细胞的任何作用都需要有激酶活性
成长。尽管Abelson蛋白改变细胞的机制
生长当然涉及到细胞内酪氨酸的磷酸化
蛋白质,对实际涉及的途径知之甚少。这个
这里提出的实验从五个方面解决了这个问题。首先,我们将
使用基因工程和生物选择的病毒来理解
蛋白质的特定部分在细胞转化中的作用
淋巴样细胞在体内和体外均有致死反应。第二,我们
将继续努力隔离显性负面转化
变种人。第三,我们将使用在
研究的前两部分,以了解突变的方式
改变Abelson蛋白的功能。第四,我们将在最近的基础上
观察到转化需要有活性的Abelson蛋白
Pre-B细胞进入细胞周期的G1期。最后,我们会
用抗-MLV条件突变体转化的前B淋巴细胞治疗
理解转型与分化之间的关系
抗体-MLV系统。总之,这些实验将有助于确定
激活的ab/基因改变细胞生长和
差异化。
英文摘要
Abelson murine leukemia virus (Ab-MLV) is a rapidly transforming retrovirus
that contains the oncogene v-abl. Expression of this or other oncogenic
forms of abl induces transformation of many types cells and stimulates the
growth and differentiation of others. In addition, expression of abl can
be lethal. All of these effects are mediated by a single product, which in
the case of Ab-MLV, is called Abelson protein. This molecule is a member
of the non-receptor protein tyrosine kinase family and the protein tyrosine
kinase activity is required for any of the effects of Ab-MLV on cell
growth. Although the mechanism by which Abelson protein alters cellular
growth most certainly involves tyrosine phosphorylation of cellular
proteins, very little is known about the actual pathways involved. The
experiments proposed here address this issue in five ways. First, we will
use genetically engineered and biologically selected viruses to understand
the role of particular portions of the protein in the transformation of
lymphoid cells in vivo and in vitro and in the lethal response. Second, we
will continue our efforts to isolate dominant negative transformation
mutants. Third, we will use the most informative mutants identified in the
first two parts of the study to understand the way in which the mutations
alter Abelson protein function. Fourth, we will build on our recent
observation that an active Abelson protein is required for transformed
pre-B cells to transit the G1 phase of the cell cycle. Finally, we will
use pre-B lymphocytes transformed by conditional mutants of Ab-MLV to
understand the relationship between transformation and differentiation in
the Ab-MLV system. Together these experiments will help determine the
mechanism by which activated ab/ genes alter cellular growth and
differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning for the Future of Dental Research and Practice
-
批准号:6695496
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2003
-
负责人:NAOMI ROSENBERG
-
依托单位:
Interdisciplinary Training Program in Cancer Genetics
-
批准号:6781409
-
项目类别:
-
资助金额:$0.24万
-
财政年份:1995
-
负责人:NAOMI ROSENBERG
-
依托单位:
Interdisciplinary Training Program in Cancer Genetics
-
批准号:6949111
-
项目类别:
-
资助金额:$30.78万
-
财政年份:1995
-
负责人:NAOMI ROSENBERG
-
依托单位:
Interdisciplinary Training Program in Cancer Genetics
-
批准号:6454125
-
项目类别:
-
资助金额:$29.89万
-
财政年份:1995
-
负责人:NAOMI ROSENBERG
-
依托单位:
Interdisciplinary Training Program in Cancer Genetics
-
批准号:6606191
-
项目类别:
-
资助金额:$32.28万
-
财政年份:1995
-
负责人:NAOMI ROSENBERG
-
依托单位:
Interdisciplinary Training Program in Cancer Genetics
-
批准号:6771881
-
项目类别:
-
资助金额:$32.1万
-
财政年份:1995
-
负责人:NAOMI ROSENBERG
-
依托单位:
KAPPA GENE REARRANGEMENT IN TRANSFORMED PREB CELLS
-
批准号:2071595
-
项目类别:
-
资助金额:$22.02万
-
财政年份:1994
-
负责人:NAOMI ROSENBERG
-
依托单位:
KAPPA GENE REARRANGEMENT IN TRANSFORMED PREB CELLS
-
批准号:2071596
-
项目类别:
-
资助金额:$24.19万
-
财政年份:1994
-
负责人:NAOMI ROSENBERG
-
依托单位:
KAPPA GENE REARRANGEMENT IN TRANSFORMED PREB CELLS
-
批准号:2071594
-
项目类别:
-
资助金额:$17.84万
-
财政年份:1994
-
负责人:NAOMI ROSENBERG
-
依托单位:
IMMUNOGLOBULIN GENES IN DIFFERENTIATING B CELLS
-
批准号:3290664
-
项目类别:
-
资助金额:$15.76万
-
财政年份:1986
-
负责人:NAOMI ROSENBERG
-
依托单位:
IMMUNOGLOBULIN GENES IN DIFFERENTIATING B CELLS
-
批准号:3290663
-
项目类别:
-
资助金额:$12.77万
-
财政年份:1986
-
负责人:NAOMI ROSENBERG
-
依托单位:
IMMUNOGLOBULIN GENES IN DIFFERENTIATING B CELLS
-
批准号:3290665
-
项目类别:
-
资助金额:$15.56万
-
财政年份:1986
-
负责人:NAOMI ROSENBERG
-
依托单位:
IMMUNOGLOBULIN GENES IN DIFFERENTIATING B CELLS
-
批准号:3290666
-
项目类别:
-
资助金额:$15.63万
-
财政年份:1986
-
负责人:NAOMI ROSENBERG
-
依托单位:
IMMUNOGLOBULIN GENES IN DIFFERENTIATING B CELLS
-
批准号:3290667
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1986
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS
-
批准号:2894553
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA Tumor Virus-Hematopoietic cell Interaction
-
批准号:7064788
-
项目类别:
-
资助金额:$32.74万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA-TUMOR VIRUS--HEMATOPOIETIC CELL INTERACTION
-
批准号:3171577
-
项目类别:
-
资助金额:$14.68万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA Tumor Virus-Hematopoietic cell Interaction
-
批准号:7234686
-
项目类别:
-
资助金额:$31.79万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTION
-
批准号:3482287
-
项目类别:
-
资助金额:$25.43万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS
-
批准号:6375658
-
项目类别:
-
资助金额:$31.7万
-
财政年份:1983
-
负责人:NAOMI ROSENBERG
-
依托单位:
海外基金